Ligand Pharmaceuticals (LGND) Deferred Taxes (2011 - 2026)
Ligand Pharmaceuticals (LGND) posted Deferred Taxes of $13.5 million for Q1 2026, up 228.01% sequentially from -$10.6 million in Q4 2025, and up 53.01% YoY from $8.8 million in Q1 2025.
Ligand Pharmaceuticals (LGND) Deferred Taxes (2011 - 2026) Analysis & Trends
Ligand Pharmaceuticals has reported Deferred Taxes for 16 years, with the latest figure at $13.5 million in Q1 2026.
- Quarterly Deferred Taxes rose 53.01% year-over-year to $13.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$18.0 million (down 140.72% YoY) and the FY2025 annual result came in at -$22.7 million, down 243.57% from the prior year.
- Deferred Taxes improved to $13.5 million in Q1 2026 per LGND's latest filing, from -$10.6 million in the prior quarter.
- Over five years, Deferred Taxes peaked at $20.7 million in Q2 2024 and troughed at -$46.3 million in Q4 2022.
- A 5-year average of -$1.5 million and a median of $325000.0 in 2025 frame the typical range for Deferred Taxes.
- The widest YoY moves for Deferred Taxes: up 922.71% in 2022, down 12000.51% in 2022.
- Over 5 years, Deferred Taxes stood at -$46.3 million in 2022, then jumped by 89.34% to -$4.9 million in 2023, then surged by 357.18% to $12.7 million in 2024, then sank by 183.29% to -$10.6 million in 2025, then surged by 228.01% to $13.5 million in 2026.
- According to Business Quant data, Deferred Taxes over the past three periods registered $13.5 million, -$10.6 million, and -$21.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -137,876.64 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.66 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Ligand Pharmaceuticals | 5.87 Bn | 4.51 Bn | 60.48 Mn | -12.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.98 Mn |
| Mar 31, 2026 | 13.53 Mn |
| Dec 31, 2025 | -10.57 Mn |
| Sep 30, 2025 | -21.28 Mn |
| Jun 30, 2025 | 325,000.00 |
| Mar 31, 2025 | 8.84 Mn |
| Dec 31, 2024 | 12.69 Mn |
| Sep 30, 2024 | 1.99 Mn |
| Jun 30, 2024 | 20.67 Mn |
| Mar 31, 2024 | -19.55 Mn |
| Dec 31, 2023 | -4.94 Mn |
| Sep 30, 2023 | -8.01 Mn |
| Jun 30, 2023 | 10.00 Mn |
| Mar 31, 2023 | -8.75 Mn |
| Dec 31, 2022 | -46.29 Mn |
| Sep 30, 2022 | 12.65 Mn |
| Jun 30, 2022 | -3.26 Mn |
| Mar 31, 2022 | 16.18 Mn |
| Dec 31, 2021 | 389,000.00 |
| Sep 30, 2021 | -1.54 Mn |